United States, March 11, 2026 /MarketersMEDIA/ — In response to the growing demand for sustainable practices in the pharmaceutical and chemical sectors, Creative Enzymes, a prominent global provider of enzyme technology services, has announced a strategic enhancement of its Biocatalysis Services. This initiative aims to facilitate a smooth transition for clients from enzyme discovery through to large-scale application, supported by a comprehensive lifecycle solution.
By integrating screening, optimisation, and industrial production, Creative Enzymes addresses the challenges associated with commercial success in the bioeconomy, where enzyme catalysis is increasingly recognised as a viable alternative to traditional chemical synthesis for producing high-purity molecules.
A critical factor influencing the success of biocatalysis projects is the precise alignment between enzymes and substrates. Many industrial initiatives face hurdles such as low conversion rates and substrate intolerance during their initial phases. To address this challenge, Creative Enzymes has introduced its advanced Biocatalyst Substrate Selection & Modification service. This service employs sophisticated computational modelling alongside experimental analysis to accurately assess substrate binding modes and reaction compatibility, while also enabling targeted modifications of active sites on both substrates and enzymes. Such tailored development enhances reaction selectivity at the molecular level, paving the way for the industrial-scale synthesis of complex chiral molecules.
Moreover, efficient Biocatalyst Substrate Profiling has emerged as a critical step in ensuring both the economic viability and stability of catalytic processes. Creative Enzymes utilises a high-throughput screening platform for comprehensive characterisation of substrate scope, kinetic parameters, and cofactor requirements. By profiling these elements, researchers can identify potential production bottlenecks early in the development process, thereby expediting research and development while minimising waste.
Creative Enzymes’ Biocatalysis Services function as an integrated closed-loop ecosystem that connects gene mining, protein engineering, and process scale-up. By combining metabolic flux analysis with genomic engineering, the company is adept at engineering sophisticated synthetic pathways, which include multi-enzyme cascade reactions and whole-cell catalysis. This end-to-end approach guarantees rigorous quality validation at every stage, from initial substrate evaluation to final product delivery.
As stated by the Chief Scientist at Creative Enzymes, “In the modern biotech landscape, we are not merely providing enzymes; we are redefining the principles of molecular construction. By merging deep scientific insights with innovative engineering, we assist our partners in enhancing production efficiency while significantly mitigating environmental impact. Our objective is to establish biocatalysis as a foundational element for every pharmaceutical entity aiming to meet carbon neutrality targets.”
Based in New York, Creative Enzymes has dedicated decades to refining its expertise in enzyme technology. Its interdisciplinary team, which includes biochemists and specialists across various related domains, offers comprehensive solutions to clients in the pharmaceutical, food, and environmental sectors. The company’s core enzyme platform has already played a pivotal role in advancing industrial-scale green synthesis and the commercial rollout of several blockbuster drug intermediates.
For more information, please contact:
- Name: Iva Colter
- Email: Send Email
- Organization: Creative Enzymes
- Website: https://www.creative-enzymes.com/